Cardinal Health Stock

$161.69

0.45% yesterday

NYSE, Jul 14, 10:15 pm CET

ISIN

US14149Y1082

Symbol

CAH

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Specialist medical trade

Overview Dividends Analysts Charts News Strategies

Cardinal Health Stock price

$161.69

+110.76 217.48% 5Y

NYSE, Closing price Mon, Jul 14 2025

+0.72 0.45%

ISIN

US14149Y1082

Symbol

CAH

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Specialist medical trade

Key metrics

Basic

Market capitalization

$38.4b

Enterprise Value

$42.8b

Net debt

$4.4b

Cash

$3.3b

Shares outstanding

239.0m

Valuation (TTM | estimate)

P/E

24.9 | 19.5

P/S

0.2 | 0.2

EV/Sales

0.2 | 0.2

EV/FCF

17.5

P/B

negative

Dividends

DPS

$2.02

Yield 1Y | 5Y

1.3% | 2.3%

Growth 1Y | 5Y

34.7% | 1.0%

Payout 1Y | 3Y

43.5% | 491.7%

Increased

1 Year

Financials (TTM | estimate)

Revenue

$222.1b | $225.6b

EBITDA

$2.7b | $3.3b

EBIT

$2.4b | $2.8b

Net Income

$1.6b | $2.0b

Free Cash Flow

$2.4b

Growth (TTM | estimate)

Revenue

0.8% | -0.5%

EBITDA

13.5% | 35.0%

EBIT

13.9% | 29.4%

Net Income

157.9% | 132.1%

Free Cash Flow

21.2%

Financial Health

Equity Ratio

-7.1%

Return on Equity

-26.5%

ROCE

18.1%

ROIC

Debt/Equity

-2.6

EPS

$6.5

FCF per Share

$10.2

Short interest

3.2%

Employees

48k

Rev per Employee

$4.7m

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Cardinal Health Stock Analysis

Unlock Scores for Free

??

22 Analysts have issued a Cardinal Health forecast:

17x Buy

77%

5x Hold

23%

More details on Analyst Estimates Including Price Targets

22 Analysts have issued a Cardinal Health forecast:

Buy

77%

Hold

23%

Analyst Estimates with Stock Price Targets

Financial data from Cardinal Health

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	222,127 222,127	1% 1% 100%
- Direct Costs	214,308 214,308	1% 1% 96%
Gross Profit	7,819 7,819	6% 6% 4%
- Selling and Administrative Expenses	5,136 5,136	3% 3% 2%
- Research and Development Expense	- -	- -
EBITDA	2,683 2,683	13% 13% 1%
- Depreciation and Amortization	287 287	10% 10% 0%
EBIT (Operating Income) EBIT	2,396 2,396	14% 14% 1%
Net Profit	1,558 1,558	158% 158% 1%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Cardinal Health Stock News

Neutral

PRNewsWire

●

3 days ago

Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy

DUBLIN, Ohio , July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists' advocacy efforts. This investment furthers Cardinal Health's longstanding advocacy around the futu...

Positive

24/7 Wall Street

●

13 days ago

5 Strong Buy-Rated Dividend Stocks Are Among the S&P 500 Top Performers in 2025

Dividend stocks are a favorite among investors for good reason.

Positive

Seeking Alpha

●

16 days ago

Best Dividend Aristocrats For July 2025

Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.

More Cardinal Health News

Company Profile

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Head office	United States
CEO	Jason Hollar
Employees	48,411
Founded	1979
Website	www.cardinalhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now